Tan CK - Search Results

1

Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma.

Chia WK, Ong S, Toh HC, Hee SW, Choo SP, Poon DY, Tay MH, Tan CK, Koo WH, Foo KF. Chia WK, et al. Among authors: tan ck. Ann Acad Med Singap. 2008 Jul;37(7):554-8. Ann Acad Med Singap. 2008. PMID: 18695766 Free article. Clinical Trial.

2

Blood aflatoxin levels in patients with hepatocellular carcinoma in Singapore.

Tan CK, Lo DS, Law NM, Ng HS, Chao TC. Tan CK, et al. Singapore Med J. 1995 Dec;36(6):612-4. Singapore Med J. 1995. PMID: 8781632

3

Screening for hepatocellular carcinoma (HCC) in a hepatitis B carrier.

Tan CK, Ng HS. Tan CK, et al. Singapore Med J. 1998 May;39(5):229-30. Singapore Med J. 1998. PMID: 9713232 No abstract available.

4

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.

Chow PK, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ, Soo KC; Asian-Pacific Hepatocellular Carcinoma Trials Group. Chow PK, et al. Among authors: tan ck. Hepatology. 2002 Nov;36(5):1221-6. doi: 10.1053/jhep.2002.36824. Hepatology. 2002. PMID: 12395333 Clinical Trial.

5

Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.

Lingegowda PB, Tan CK, Tan AL, Tan BH. Lingegowda PB, et al. Among authors: tan al, tan ck, tan bh. Ann Acad Med Singap. 2011 Jun;40(6):287-90. Ann Acad Med Singap. 2011. PMID: 21779617 Free article.

6

Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.

Wang WW, Ang SF, Kumar R, Heah C, Utama A, Tania NP, Li H, Tan SH, Poo D, Choo SP, Chow WC, Tan CK, Toh HC. Wang WW, et al. Among authors: tan ck, tan sh. PLoS One. 2013 Jul 18;8(7):e68904. doi: 10.1371/journal.pone.0068904. Print 2013. PLoS One. 2013. PMID: 23874805 Free PMC article.

7

The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.

Ang SF, Ng ES, Li H, Ong YH, Choo SP, Ngeow J, Toh HC, Lim KH, Yap HY, Tan CK, Ooi LL, Cheow PC, Chung AY, Chow PK, Foo KF, Tan MH. Ang SF, et al. Among authors: tan mh, tan ck. PLoS One. 2015 Apr 1;10(4):e0118658. doi: 10.1371/journal.pone.0118658. eCollection 2015. PLoS One. 2015. PMID: 25830231 Free PMC article.

8

Correction: The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma.

Ang SF, Ng ES, Li H, Ong YH, Choo SP, Ngeow J, Toh HC, Lim KH, Yap HY, Tan CK, Ooi LL, Cheow PC, Chung AY, Chow PK, Foo KF, Tan MH. Ang SF, et al. Among authors: tan mh, tan ck. PLoS One. 2015 May 13;10(5):e0128058. doi: 10.1371/journal.pone.0128058. eCollection 2015. PLoS One. 2015. PMID: 25970288 Free PMC article. No abstract available.

9

Epidemiology and Clinical Evolution of Liver Cirrhosis in Singapore.

Chang PE, Wong GW, Li JW, Lui HF, Chow WC, Tan CK. Chang PE, et al. Among authors: tan ck. Ann Acad Med Singap. 2015 Jun;44(6):218-25. Ann Acad Med Singap. 2015. PMID: 26292950 Free article.

10

Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy.

Chay WY, Tham CK, Toh HC, Lim HY, Tan CK, Lim C, Wang WW, Choo SP. Chay WY, et al. Among authors: tan ck. J Altern Complement Med. 2017 Aug;23(8):648-652. doi: 10.1089/acm.2016.0136. Epub 2017 Apr 4. J Altern Complement Med. 2017. PMID: 28375640 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters